Advfn moneymunch (quoted)13 Apr 2018 07:25
moneymunch: A game changer ahead and potential multi-bag ( Double figures more than possible ) on disclosure of Microsaic's global biopharma partner on successful technology trials and already validated by their partner's BIG pharma end users and on-going integration into their partner's product equipment..Gla holders.....On and Up!!!;-) Q1: Microsaic recently announced the signing of a research agreement with a global partner in biopharma, can you tell us a little bit more about that? A1: Yes, absolutely so Ive got to say that we are under strict NDA in this particular case but what I can do is give you some context. Earlier in the year we successfully completed a significant joint feasibility phase to show dedicated at-line mass spec can assess the quality of biologics during the manufacture. I think perhaps the most important aspect of that phase was that we had substantial end-user validation from big pharma and just to say that these are end-users whom our partner has very good global reach. What this new phase is it will bring more end-user validation to the approach, but I think the exciting deliverable is that we'll be able to provide a lot more technical integration with the partners product. So, should this activity be successful, it will take us into the second half of 2018 and then that will proceed a period of productisation. As I said, I can't give any details yet about the size and timeline for commercialisation, but the opportunity is significant to us, to Microsaic, and delivery is proportionate, I would say, to our timescales.
Read Full ThreadFollowReply
Sign In
Follow the stocks
